293 related articles for article (PubMed ID: 22595010)
1. Modulators of Na/K-ATPase: a patent review.
Wang HY; O'Doherty GA
Expert Opin Ther Pat; 2012 Jun; 22(6):587-605. PubMed ID: 22595010
[TBL] [Abstract][Full Text] [Related]
2. Istaroxime, a novel luso-inotropic agent for the treatment of acute heart failure.
Wehrens XH
Curr Opin Investig Drugs; 2007 Sep; 8(9):769-77. PubMed ID: 17729189
[TBL] [Abstract][Full Text] [Related]
3. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na(+)/K(+)-ATPase.
Zeino M; Brenk R; Gruber L; Zehl M; Urban E; Kopp B; Efferth T
J Steroid Biochem Mol Biol; 2015 Jun; 150():97-111. PubMed ID: 25797029
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic applications of cardiac glycosides.
Prassas I; Diamandis EP
Nat Rev Drug Discov; 2008 Nov; 7(11):926-35. PubMed ID: 18948999
[TBL] [Abstract][Full Text] [Related]
6. Na+/K+-ATPase and cancer.
Mijatovic T; Dufrasne F; Kiss R
Pharm Pat Anal; 2012 Mar; 1(1):91-106. PubMed ID: 24236716
[TBL] [Abstract][Full Text] [Related]
7. Redox-dependent regulation of the Na⁺-K⁺ pump: new twists to an old target for treatment of heart failure.
Liu CC; Fry NA; Hamilton EJ; Chia KK; Garcia A; Karimi Galougahi K; Figtree GA; Clarke RJ; Bundgaard H; Rasmussen HH
J Mol Cell Cardiol; 2013 Aug; 61():94-101. PubMed ID: 23727392
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Na+,K(+)-ATPase by flavonoids and their inotropic effect. Investigation of the structure-activity relationship.
Umarova FT; Khushbactova ZA; Batirov EH; Mekler VM
Membr Cell Biol; 1998; 12(1):27-40. PubMed ID: 9829256
[TBL] [Abstract][Full Text] [Related]
9. Local and systemic effects of Na+/K+ATPase inhibition.
Joubert PH; Grossmann M
Eur J Clin Invest; 2001; 31 Suppl 2():1-4. PubMed ID: 11525232
[TBL] [Abstract][Full Text] [Related]
10. Na+/K+ ATPase inhibitors in cancer.
Alevizopoulos K; Calogeropoulou T; Lang F; Stournaras C
Curr Drug Targets; 2014; 15(10):988-1000. PubMed ID: 25198786
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of novel sodium/potassium-ATPase inhibitors by virtual screening of a compound database.
Stanton DT; Ankenbauer J; Rothgeb D; Draper M; Paula S
Bioorg Med Chem; 2007 Sep; 15(18):6062-70. PubMed ID: 17618121
[TBL] [Abstract][Full Text] [Related]
12. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
Schoner W; Scheiner-Bobis G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of the Na+, K+-ATPase digitalis binding site.
Keenan SM; DeLisle RK; Welsh WJ; Paula S; Ball WJ
J Mol Graph Model; 2005 Jun; 23(6):465-75. PubMed ID: 15886034
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the alpha1beta1 isoform of the Na, K-ATPase by 8-methoxycoumestrol without positive inotropic effect in human myocardium--novel aspects of cardiac glycoside pharmacology.
Potter T; Hauck C; Pôças ES; Diedrichs H; Adam C; Reuter H; Wittwer T; Wahlers T; da Silva AJ; Costa PR; Noël F; Müller-Ehmsen J
J Cardiovasc Pharmacol; 2009 Jul; 54(1):10-5. PubMed ID: 19487957
[TBL] [Abstract][Full Text] [Related]
15. Characterization, quantitation, similarity evaluation and combination with Na
Bai Y; Zhu W; Xu Y; Xie Z; Akihisa T; Manosroi J; Sun H; Feng F; Liu W; Zhang J
Bioorg Chem; 2019 Jun; 87():265-275. PubMed ID: 30908969
[TBL] [Abstract][Full Text] [Related]
16. From Na+/K+-ATPase and cardiac glycosides to cytotoxicity and cancer treatment.
Babula P; Masarik M; Adam V; Provaznik I; Kizek R
Anticancer Agents Med Chem; 2013 Sep; 13(7):1069-87. PubMed ID: 23537048
[TBL] [Abstract][Full Text] [Related]
17. Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs?
Chen JQ; Contreras RG; Wang R; Fernandez SV; Shoshani L; Russo IH; Cereijido M; Russo J
Breast Cancer Res Treat; 2006 Mar; 96(1):1-15. PubMed ID: 16322895
[TBL] [Abstract][Full Text] [Related]
18. Na+,K(+)-ATPase inhibiting activity of cardiac glycosides from Erysimum cheiranthoides.
Lei ZH; Kuniyasu A; Tai BS; Nakayama H; Nohara T
Planta Med; 2001 Jun; 67(4):369-70. PubMed ID: 11458460
[TBL] [Abstract][Full Text] [Related]
19. The Na(+), K(+)-ATPase: more than just a sodium pump.
Scheiner-Bobis G
Cardiovasc Res; 2011 Jan; 89(1):6-8. PubMed ID: 21097805
[No Abstract] [Full Text] [Related]
20. Cardiotonic steroid-resistant alpha1-Na+,K+-ATPase rescues renal epithelial cells from the cytotoxic action of ouabain: evidence for a Nai+,Ki+ -independent mechanism.
Akimova OA; Tremblay J; Van Huysse JW; Hamet P; Orlov SN
Apoptosis; 2010 Jan; 15(1):55-62. PubMed ID: 19949978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
